Literature DB >> 11124851

The CYP2E1 knockout delivers another punch: first ASH, now NASH. Alcoholic steatohepatitis. Nonalcoholic steatohepatitis.

J Maher1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11124851     DOI: 10.1053/jhep.2001.0330311

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  5 in total

Review 1.  Mechanisms and cell signaling in alcoholic liver disease.

Authors:  Juliane I Beier; Craig J McClain
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

2.  Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway.

Authors:  Qiang Ou; Yuanyuan Weng; Siwei Wang; Yajuan Zhao; Feng Zhang; Jianhua Zhou; Xiaolin Wu
Journal:  Dig Dis Sci       Date:  2018-09-06       Impact factor: 3.199

3.  Relationship between genetic polymorphism of cytochrome P450IIE1 and fatty liver.

Authors:  Yun-Feng Piao; Jing-Tao Li; Yang Shi
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

4.  Ethanolic Extract of Acanthopanax koreanum Nakai Alleviates Alcoholic Liver Damage Combined with a High-Fat Diet in C57BL/6J Mice.

Authors:  Haein Kim; Minyoung Park; Jae-Ho Shin; Oran Kwon
Journal:  Molecules       Date:  2016-05-24       Impact factor: 4.411

5.  Influence of fat/carbohydrate ratio on progression of fatty liver disease and on development of osteopenia in male rats fed alcohol via total enteral nutrition (TEN).

Authors:  Martin J J Ronis; Kelly Mercer; Larry J Suva; Jamie Vantrease; Matthew Ferguson; William R Hogue; Neha Sharma; Mario A Cleves; Michael L Blackburn; Thomas M Badger
Journal:  Alcohol       Date:  2014-02-01       Impact factor: 2.405

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.